SCHEMBL24564366

SCHEMBL24564366

CN(N)C1CCCCOC1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ADH1C P00326 1/20 0.31
ADH1A P07327 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18938291 0.84
SCHEMBL24814059 0.84
SCHEMBL24815132 0.84
SCHEMBL17517731 0.82 ADH1C (0.33) ADH1CADH1A
SCHEMBL17431789 0.80 ADH1C (0.37) ADH1CADH1A
SCHEMBL389800 0.75
SCHEMBL24044715 0.75 ADH1B (0.34) ADH1CADH1A
SCHEMBL13345923 0.75
SCHEMBL10339953 0.75
SCHEMBL15360232 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3630771-B1 5,6-FUSED-BICYCLIC COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES NOVARTIS AG (CH) 2022-06-29 EP disclosed